丽珠医药(01513)9月12日斥资342.75万元回购8.53万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 85,300 A-shares at a cost of 3.4275 million yuan by September 12, 2025 [1] Company Summary - The company plans to spend 3.4275 million yuan for the buyback [1] - The total number of shares to be repurchased is 85,300 A-shares [1]